Deferred Tax Assets, Valuation Allowance in USD of Rallybio Corp from Q4 2020 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Rallybio Corp quarterly Deferred Tax Assets, Valuation Allowance history and change rate from Q4 2020 to Q4 2024.
  • Rallybio Corp Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $98M, a 25.2% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Rallybio Corp Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $98M +$19.7M +25.2% 31 Dec 2024 10-K 13 Mar 2025
Q4 2023 $78.3M +$28.1M +55.9% 31 Dec 2023 10-K 13 Mar 2025
Q4 2022 $50.2M +$19.1M +61.1% 31 Dec 2022 10-K 12 Mar 2024
Q4 2021 $31.2M +$15.8M +103% 31 Dec 2021 10-K 06 Mar 2023
Q4 2020 $15.3M 31 Dec 2020 10-K 15 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.